macimorelin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
growth hormone release-stimulating peptides 5271 381231-18-1

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • macimorelin
  • macimorelin acetate
  • D-87575
  • EP1572
  • ARD 07
Macimorelin stimulates GH release by activating growth hormone secretagogue receptors present in the pituitary and hypothalamus.
  • Molecular weight: 474.57
  • Formula: C26H30N6O3
  • CLOGP: 1.60
  • LIPINSKI: 1
  • HAC: 9
  • HDO: 6
  • TPSA: 144.90
  • ALOGS: -4.90
  • ROTB: 9
  • Status: OFM
    • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

None

ADMET properties:

None

Approvals:

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Drug Use | Suggest Off label Use Form| |View source of the data|




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Orange Book patent data (new drug applications)

Orange Book exclusivity data (new drug applications)

Bioactivity Summary:

External reference:

Pharmaceutical products:

macimorelin